Jie Chen
Li Jin
Mengyao Chen1†
Beihui He- 1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China
- 2School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China
Prediabetes is an intermediate stage in the development of type 2 diabetes mellitus characterized by impaired fasting glucose and/or impaired glucose tolerance. Prediabetes generally has no obvious clinical symptoms, and most patients are found in health examinations or due to other diseases. Reactive hypoglycemia may indicate the possibility of early diabetes. Without effective preventive measures, prediabetes can progress to diabetes leading to serious public health problems. Therefore, early diagnosis and intervention are important. Many animal experiments and clinical trials have proven that natural compounds substantially improve glucose metabolism disorder. The active ingredients are mainly alkaloids, polysaccharides, saponins, terpenoids, flavonoids and polyphenols. Their mechanism of action mainly involves improved insulin sensitivity and insulin resistance, inhibited activity of alpha-glucosidase, antioxidant activity, anti-inflammatory, regulation of gut microbiota and activating of peroxisome proliferator-activated receptor-γ. This paper reviews the mechanisms of action of natural compounds on prediabetes and the status of related research.
1 Introduction
Diabetes is a chronic disease that seriously affects the quality of life of patients. It includes different types, of which type 2 diabetes (T2D) accounts for the majority. Prediabetes is an intermediate stage of glucose dysregulation (1) that consists of impaired fasting glucose (IFG) (6.1 mmol/L ≤ fasting plasma glucose<7.0 mmol/L), impaired glucose tolerance (IGT) (fasting plasma glucose<6.1 mmol/L and 7.8 ≤ 2-h fasting plasma glucose<11.1 mmol/L), or both. Both IFG and IGT have both insulin resistance and beta-cell defect, postprandial reactive hypoglycemia is also known as prediabetic reactive hypoglycemia because it may be associated with IFG and/or IGT (2). An estimated 280 million people currently have prediabetes. This number is projected to reach 548 million by 2045, accounting for 8.4% of global adult population (3, 4). Approximately 5 to 10% of patients with prediabetes will progress to diabetes without effective preventive measures each year (5). The prevention of diabetes is an urgent issue.
The pathogenesis of prediabetes is not fully understood and may involve insulin resistance (IR), chronic inflammatory responses, pancreatic beta cell dysfunction, oxidative stress, gut microbiota (6).
Lifestyle intervention is the first-line approach to prevent or delay T2D in adults with prediabetes (7). Drug therapy is necessary if lifestyle interventions fail (8). Although drug interventions such as metformin, α-glycosidase enzyme inhibitor, GLP-1 receptor agonist, SGLT2 inhibitor, thiazolidinedione can reduce the risk of diabetes in prediabetes (9, 10), but adverse reactions, such as diarrhea and abdominal distension, huge cost should become prehensive considered for long-term use (11). Natural compounds increasing attention owing to their safety, few side effects, and definite curative effects mainly involves improved insulin sensitivity and insulin resistance, inhibited activity of alpha-glucosidase, antioxidant activity, anti-inflammatory, regulation of gut microbiota (12). Natural compounds have good anti diabetes and prediabetes properties, mainly including phenolic compounds, flavonoids, terpenoids, alkaloids, glycosides, quinones, lactones and saponins (13).
This paper reviews the mechanisms of action of natural compounds on prediabetes and the related research status. The intent is to provide an important basis and new research mentality for the development and application of natural compounds.
2 Active ingredients of natural compounds
Natural compounds with varying biological and pharmacological activities for prediabetes include flavonoids, polyphenols, terpenoids, alkaloids, polysaccharides, quinones, lactones, and saponins. Progresses of natural compounds in anti prediabetes in vivo, in vitro and clinical trials have shown in Table 1.
Table 1. Progress of natural compounds in anti prediabetes in vivo, in vitro and clinical trials.
2.1 Alkaloids
In one study, Sangzhi alkaloid was administered for 6 weeks to prediabetic HFC mice. The intervention significantly lowered fasting blood glucose (FBG), random blood glucose, fasting insulin, and total cholesterol (TC); improved glucose and lipid metabolism and IR; and ameliorated glucose tolerance through increasing the insulin secretion multiple by 51.3% after 15 min of glucose stimulation (p = 0.07) (14). Wang et al. (15) established an IGT rat model using a high-energy diet. After 3 weeks of berberine treatment, diabetes developed in all rats in the model group, but in only 30% of rats in the treatment group. The FBG level in the berberine group (5.03 ± 1.26 mmol/L) was significantly lower than that in the IGT group (p < 0.05). These results showed that berberine delayed the progression of prediabetes to T2DM in IGT rats by improving the structure of the gut microbiota and intestinal permeability.
2.2 Polysaccharides
Deng et al. (16) used astragalus polysaccharide as an intervention to treat insulin cells exposed to high glucose and palmitic acid. Astragalus treatment ameliorated proliferation and insulin secretion in dysfunctional cells partially by upgrading the expression of microRNA (miR)-149-5p and miR-136-5p. Guargum is a natural polysaccharide extracted from the seeds of the Cyamopsistetragonolobus guar plant. Clifton et al. (17) recruited prediabetic and moderately well-controlled T2D patients who consumed a drink consisting mainly of guar gum for 2 days or cold water on the other 2 days before breakfast. Three-hour glucose finger prick test measurements demonstrated an obvious decrease at every time point, peak finger prick glucose was reduced by 2.1 mmol/L at 45 min (p < 0.0001). Average finger prick glucose over 3 h was reduced by 0.8 mmol/L (p = 0.0003).
2.3 Saponins
The preventive administration of saponins of panax ginseng was given to Sprague Dawley (SD) rats, then diabetic rat model was induced in SD rats by streptozocin administration. The outcome showed that SD rats pretreated with saponins of panax ginseng did not develop diabetes (18). Guo et al. (19) administer edlitchiseed saponin to hyperlipidemia-fatty, liver-insulin-resistant rats. After administration of litchi seed saponin, the FBG and 2 h PG significantly decreased (p < 0.05), IGT improved, and the levels of TC, triglyceride (TG), and low-density lipoprotein-cholesterol (LDL-C) decreased, with improved insulin sensitivity. Martínez et al. (20) studied the administration of Gymnema sylvestre leaf extract containing at least 23 saponins to an IGT population. The extract significantly reduced glycated hemoglobin (HbA1c) levels (5.8 ± 0.3% vs. 5.4 ± 0.4%, p = 0.025), and 2-h PG levels (9.1 ± 1.2 vs. 7.8 ± 1.7 mmol/L, p = 0.003) after the oral glucose tolerance test compared to baseline, thereby improving insulin sensitivity.
2.4 Terpenoids
Gamede et al. (21) established prediabetes in SD rats by feeding them a high-carbohydrate high-fat diet. The prediabetic rats were then treated with oleanolic acid for 12 weeks. Oleanolic acid upgraded lipid metabolism by recovering LDLs and high-density lipoproteins, while decreasing immune cell and platelet counts. Oleanolic acid also reduced plasma level of proinflammatory cytokines, including containing tumor necrosis factor-1β and tumor necrosis factor-α. Immune activation markers, such as fibrinogen, C-reactive protein, and CD40L, were also reduced after the administration of oleanolic acid. According to a clinical trials related to Oleanolic acid (OA), 176 prediabetes individuals were recruited, 55 mL/day of olive oil rich in OA (equivalent to a dose of 30 mg OA/day) was given, the results showed that the intake of olive oil rich in OA can reduce the risk of diabetes in pre diabetes patients, thus promoting the use of OA in new functional foods and drugs to prevent individuals at risk of diabetes (24). Wei (25) recruited 86 prediabetic patients and randomly assigned them to control and treatment groups. Both groups underwent 3 months of diet control and exercise. Those in the treatment group additionally received Jiawei Yueju Decoction, whose main active ingredients include geniposide, the main components of iridoids, which had been demonstrated to reduce blood glucose levels in mice in a dose-dependent manner. After 3 months of treatment, FBG, 2-h PG and HbA1c decreased significantly in the treatment group (p < 0.05), with reductions in in TG, TC, and LDL-C levels that were more obvious than the reductions in the control group (p < 0.05). Mayasari et al. (26) observed the effect of a mixed herbal drink consisting of Stevia rebaudiana (steviol diterpene glycosides are natural compounds of S. rebaudiana leaves that impart sweetness) and Hibiscus sabdariffa (rosella tea) on glucose metabolism in women with prediabetes. Half the women consumed the mixed herbal drink and the other half consumed a control drink lacking steviol diterpene glycosides. After 14 days, a significant decrease in FPG levels was observed in the treatment group (from 111.25 ± 7.20 mg/dL to 88.58 ± 13.19 mg/dL; p < 0.01). Zhang et al. (22) established insulin resistant rats induced by high fat diets, after 4 weeks and 8 weeks administration, they found ursolic acid could markedly reduce the levels of fasting serum insulin, HOMA-IR, serum total cholesterol, triglyceride, and improve the insulin sensitive index, which means ursolic acid could improve insulin resistance which is the main reason for prediabetes. In previous studies, bredemolic acid has been reported as an antidiabetic agent that improves glucose uptake, ameliorates insulin resistance, and oxidative stress in the liver, heart, kidney, and skeletal muscle of prediabetic rats. Insulin resistance was induced in the skeletal muscle cells after 4 h of exposure to palmitic acid (0.5 mmol/L), and then treated with either insulin (4 μg/mL) or bredemolic acid (12.5 mmol/L) or with both. The results showed that bredemolic acid significantly improved TOAC and promoted glucose utilization via attenuation of lipid peroxidation and increased glycogen formation in the insulin-resistant cells, respectively (23).
2.5 Flavonoids
Cesar et al. (27) treated prediabetic patients with the nutraceutic alerythromycin, a compound of citrus flavonoids (naringin, hesperidin, eriocitrin, and didymin). Glycemia was reduced and glucagon-like peptide-1 (GLP-1), butyrate and acetate production increased. 16rRNA gene sequencing showed that eriomin provoked the growth of Subdoligranulum and Bacteroides, which are related to superior host glycemic metabolism. Xian et al. (28) collected data from middle-aged and elderly women with prediabetes and found that tea made from guava leaves, which contain flavonoids as one of the main active ingredients, was one of the most effective hypoglycemic treatments along with diabetes education in the 3-month treatment period. Levels of FBG, 2 h-PG, and HbA1c in these patients were significantly better than the levels in the control group (p < 0.05). Finally, the positive effect of quercetin on glucose homeostasis by reducing FPG levels and Homeostatic Model Assessment for IR (HOMA-IR) values has been reported (p < 0.001) (29). Quercetin is a major member of the flavonoid family found in various vegetables and fruits.
2.6 Polyphenols
Chen et al. (30) randomly patients with newly prediabetes or T2D into control and treatment groups, using the patient’s own body as a control. The treatment group was treated with Elitea Essence, a Pu-erh tea extract whose main ingredient is polyphenols. Both groups underwent a 100-g steamed-bread meal test. C-peptide, insulin, and GLP-1 levels were significantly higher following treatment (p < 0.05), indicating that Elitea Essence could enhance postprandial insulin secretion from pancreatic β cells, and suppress glucagon secretion, thereby lowering postprandial blood glucose levels of IGT. Chuengsamarn et al. (31) recruited 240 patients with prediabetes. They received placebo capsules or curcumin. After 9 months of treatment, none of the subjects in the curcumin-treated group were diagnosed with T2DM, while a small number of subjects in the placebo control group were diagnosed with T2DM. In addition, the curcumin group showed a superior overall function of β-cells, with lower C-peptide (1.7 vs. 2.17, p < 0.05) and higher HOMA-β (61.58 vs. 48.72, p < 0.01). The curcumin-treated patients displayed higher adiponectin levels and lower HOMA-IR values compared with the control group (3.22 vs. 4.04, p < 0.001). Lignans are natural compounds isolated from nutmeg. Finite evidence indicates the short- and long-term efficacy of lignans in managing at least three of seven conditions (central obesity, hyperglycemia, hypertension, dyslipidemia, pro-thrombosis, oxidation, and inflammation) prior to and following the onset of T2D. Large multicenter clinical trials are required to determine the potential of lignans in prediabetes and T2D (32).
3 Mechanism of action of natural compounds
3.1 Improve insulin sensitivity and IR
Guava leaf tea, which contains flavonoids as the main active ingredient, is one of the most effective hypoglycemic therapies. Consumption of this tea can increase glucose uptake and utilization by the peripheral tissues, improve insulin sensitivity, protect islet β cells, and ultimately meliorate the metabolism of glucose (28). In one study, treatment with guava leaf tea improved blood sugar levels in middle-aged and elderly women with prediabetes (28). Curcumin, the main active part of the spice turmeric kurkum, is collected from the rhizome of the tropical plant Curcuma longa L. Curcumin is recommended to prevent the progression of prediabetes to diabetes based on its proven safety and efficacy. The efficacy mainly involves improving β-cell function, preventing β-cell apoptosis, and reducing IR (31). Chlorogenic acid is a major polyphenol found in green coffee beans. It seems to have hypoglycemic functions resembling those of metformin by improving glucose uptake and IR without side effects, thus decreasing FPG and increasing insulin sensitivity in patients with IGT (33). Fenugreek powder is useful in reducing the cumulative incidence rate of prediabetes. After treatment with fenugreek powder in a prediabetic population, the development of diabetes was definitely related to serum insulin and negatively associated with HOMA-IR. The main mechanism may involved decreased IR (34). Ilex paraguariensis is a perennial tree that grows in southern Brazil. Extracts have shown potential benefits to human health, such as hypoglycemic effects, weight reduction, and high antioxidant activity, due to the presence of various bioactive compounds, including polyphenols, saponins, and flavonoids. Treatment reportedly reduced FPG and HOMA-IR levels by improving IR in patients with prediabetes (35). Nuciferine is a natural compound found in lotus leaves. The variety of physiological activities and pharmacological effects include antidiabetic and antioxidant effects. Following consumption, nuciferine becomes densely distributed on the intestinal wall, creating a layer that can retain fat. This activity restricts the absorption of fat, inhibits fat accumulation, reduces body weight, and improves insulin sensitivity, thus preventing or delaying the progression from prediabetes to diabetes (36). Aspergillus dracunculus is a representative medicinal plant. Estragole is the main compound responsible for the antihyperglycemic properties of A. dracunculus. The toxicity of estragole may be removed by the preparation of an ethanol extract. One study found that the ethanol extract of A. dracunculus in patients with IGT decreased the area under the receive operating characteristic curve of insulin and total insulin secretion (37). Remarkable reductions in HbA1c and blood pressure were evident, due to increases of insulin sensitivity and insulin signaling. These increases resulted from the activated activity of the insulin receptor substrate associated with AKT1, phosphoinositide 3-kinase, and phosphorylation of AKT in skeletal muscle.
3.2 Inhibition of alpha-glucosidase activity
Sangzhi alkaloids are highly selective disaccharidase inhibitors that prevent the enzymatic hydrolysis of carbohydrates by inhibiting α-glucosidase activity, which controls postprandial elevation in blood glucose. Long-term treatment may be beneficial to delay the progression prediabetes to diabetes (14). In one study, the long-term administration of this drug effectively improved glucose and lipid metabolism in prediabetic mice. Timosaponin AIII is a steroidal saponin extracted from Anemarrhena asphodeloides. It inhibits α-glucosidase activity, which can postpone or decrease the digestion and absorption of carbohydrates, reduce the postprandial blood glucose level, reduce blood sugar fluctuations, and delay or prevent diabetes (38). Anthocyanins are glycosides of anthocyanidins. Anthocyanins are a subclass of flavonoids that are responsible for the deep blue, purple, and red colors of many vegetables and fruits. Anthocyanidins and their glycosides can inhibit α-amylase and α-glucosidase activities and improve the expression of glucose transporter 4 in cell membranes. These activities improve the lipid profile and promote glucose uptake, which can delay the onset of diabetes (39).
3.3 Decreased oxidative stress
Increased oxidative stress and decreased antioxidant activity are associated with prediabetes and diabetes. Anthocyanins have shown promising antioxidant and antidiabetic effects (39). Flavonoids in buckwheat decrease high glucose-induced oxidative stress. Flavonoids also significantly inhibit the production of reactive oxygen species (ROS) and improve glucose consumption and glycogen content in HepG2 cells, thus showing appreciable antioxidant and antidiabetic characteristics (40). Ginseng contains various compounds. Among these, ginsenosides have been implicated in its hypoglycemic action. The preventive effect of saponins from Panax ginseng is related to the antioxidative stress activity involving decreased malondialdehyde (MDA) and ROS levels, and increased superoxide dismutase (SOD) levels, thus preventing diabetes onset and retarding its progression (41).
3.4 Anti-inflammatory effect
Chinese yam polysaccharides reduce the body weight of obese mice. The polysaccharides also ameliorate IR by reducing serum inflammatory factors interleukin (IL)-10, IL-1β, and leptin, and increasing insulin sensitivity (41). OA may offer an alternative to hinder the progression of prediabetes to diabetes. A decrease in proinflammatory cytokine levels indicates that OA has anti-inflammatory properties involving a weakened innate immune cell response and inhibited production of proinflammatory cells in prediabetic individuals (21).
3.5 Regulation of gut microbiota
Eriomin is a mixture of the citrus flavonoids hesperidin, naringin, eriocitrin and didymin. Eriomin treatment of prediabetic patients resulted in significantly increased beta diversity, indicating an influence on the gut microbiota (27). Acetate and butyrate production were increased and the growth of Bacteroides and Suboligranulum was stimulated. Bacteroides comprise the largest portion of the intestinal microbiota and are latent colonizers of the colon, with some species generating acetic and propionic fatty acids. Suboligranulum species are associated with improved glycemic metabolism in the host. Finally, the demonstration that eriomin improves the composition and metabolism of the gut microbiota indicates its potential value as a treatment of prediabetes (27). Berries that are rich in polyphenol regulate intestinal microflora ecology by reversing/reducing the high-carbohydrate/high-fat-induced alterations in glucose metabolism-related pathways. These events result in a decline in the Bacteroidetes/Firmicutes ratio, short-chain fatty acids, and organic acid-producing microflora (42). Berberine is a natural product belonging to a group of alkaloids presents in many medicinal plants. In one study, berberine appeared to postpone the progression of prediabetes to T2D in ZDF rats by recovering the structure of the gut microbiota and intestinal permeability, as well as the abundance of gram-negative bacteria (15). Dendrobium officinale polysaccharides are the major active ingredients in D. officinale. The polysaccharides serve as prebiotics and have various biological activities, including hypoglycemic activity. Finally, treatment with D. officinale polysaccharides decreased the Bacteroidetes/Firmicutes ratio and increased the abundance of Bifidobacterium and Lactobacillus, thereby preventing the progression of prediabetes to diabetes (43).
3.6 Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation
Curcumin is a polyphenolic compound isolated from turmeric. Similar to the oral hypoglycemic drug thiazolidinedione, curcumin can activate PPAR-γ, thereby reducing blood sugar levels. PPAR-γ activation leads to suppression of gluconeogenesis and enhancement of glucose uptake and insulin sensitivity (44). Banaba is a deciduous tropical tree containing several polyphenolic compounds. Choi et al. (45) compared the hypoglycemic actions of banaba extract and soybean leaf extract in patients with prediabetes for 12 weeks. Both extracts similarly reduced HbA1c levels. In addition, patients treated with either extract displayed significantly reduced levels of baseline-adjusted final FPG and HOMA-IR compared with the control group. The hypoglycemic effect of banaba seems to reflect multiple mechanisms, including enhanced insulin sensitivity, by improving the expression of liver PPAR-α mRNA and adipose tissue PPAR-γ mRNA, thus reducing the risk of IGT progressing toward overt diabetes (Figure 1).
Figure 1. Mechanism of action for the effect of natural compounds.
4 Conclusions and outlook
Our findings suggest a role for some natural compounds, such as Berberis, Curcumin, Panax ginseng and Oleanolic acid, in the management of prediabetes. With a large number of phenolic compounds, flavonoids, terpenoids, alkaloids, glycosides, quinones, lactones, and saponins, natural compounds have varying biological and pharmacological activities for prediabetes. The mechanism of prediabetes treatment by natural compounds might be related to decreased IR, reduced lipogenesis, oxidative stress, and inflammation, and improved function of β-cells function. While natural compounds have great potential for the treatment of prediabetes, current research and applications are relatively limited. Further studies focusing on the mechanism of action and active ingredients of natural compounds need to be performed using modern scientific and technological means to provide evidence-based support for their rational clinical application. In addition, a systematic safety review, including the safety and efficacy of natural compounds, requires further improvement. The present review provides the theoretical basis and fundamental scientific data for further research and the application of natural compounds in the treatment of prediabetes.
Author contributions
JC: Writing – original draft. LJ: Writing – original draft. MC: Writing – original draft. KX: Writing – original draft. BH: Writing – original draft, Writing – review & editing. QH: Writing – review & editing.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The study is supported by Administration of Traditional Chinese Medicine of Zhejiang Province (No. 2022ZA070) and Healthy China Traditional Chinese Medicine Special Action (Inheritance and Development of Traditional Chinese Medicine) (No. 1Z22205).
Acknowledgments
We would like to thank Editage (www.editage.cn) for English language editing.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Echouffo-Tcheugui, JB, Perreault, L, Ji, L, and Dagogo-Jack, S. Diagnosis and management of prediabetes: a review. JAMA. (2023) 329:1206–16. doi: 10.1001/jama.2023.4063
2. Altuntaş, Y . Postprandial reactive hypoglycemia. Sisli Etfal Hastan Tip Bul. (2019) 53:215–20. doi: 10.14744/SEMB.2019.59455
3. Echouffo-Tcheugui, JB, and Selvin, E. Prediabetes and what it means: the epidemiological evidence. Annu Rev Public Health. (2021) 42:59–77. doi: 10.1146/annurev-publhealth-090419-102644
4. Fukushima, T, Chubachi, S, Namkoong, H, Asakura, T, Tanaka, H, Lee, H, et al. Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID-19: integrative analysis from the Japan COVID-19 task force. Diabetes Obes Metab. (2023) 25:144–55. doi: 10.1111/dom.14857
5. Sun, H, Saeedi, P, Karuranga, S, Pinkepank, M, Ogurtsova, K, Duncan, BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. (2022) 183:109119. doi: 10.1016/j.diabres.2021.109119
6. Tabák, AG, Herder, C, Rathmann, W, Brunner, EJ, and Kivimäki, M. Prediabetes: a high-risk state for diabetes development. Lancet. (2012) 379:2279–90. doi: 10.1016/S0140-6736(12)60283-9
7. Peña, A, Olson, ML, Hooker, E, Ayers, SL, Castro, FG, Patrick, DL, et al. Effects of a diabetes prevention program on type 2 diabetes risk factors and quality of life among Latino youths with prediabetes: a randomized clinical trial. JAMA Netw Open. (2022) 5:e2231196. doi: 10.1001/jamanetworkopen.2022.31196
8. Li, Z-r, and Liu, S-j. Research on the basis of diagnosis and treatment of traditional Chinese and Western medicine in pre-diabetes based on the new version of diabetes guidelines in China and abroad. World J Integr Trad Western Med. (2023) 18:472–477+496. doi: 10.13935/j.cnki.sjzx.230309
9. Sardu, C, D'Onofrio, N, Torella, M, Portoghese, M, Loreni, F, Mureddu, S, et al. Pericoronary fat inflammation and major adverse cardiac events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin. Cardiovasc Diabetol. (2019) 18:126. doi: 10.1186/s12933-019-0931-0
10. Baxter, NT, Lesniak, NA, Sinani, H, Schloss, PD, and Koropatkin, NM. The Glucoamylase inhibitor Acarbose has a diet-dependent and reversible effect on the murine gut microbiome. mSphere. (2019) 4:e00528–18. doi: 10.1128/mSphere.00528-18
11. Ren, G, Ma, X, and Jiao, P. Effect of liraglutide combined with metformin or acarbose on glucose control in type 2 diabetes mellitus and risk factors of gastrointestinal adverse reactions. Am J Transl Res. (2022) 14:3207–15.
12. Yang, Q, Yang, L, Qiu, L, Zhang, D, and Shi, X. Research progress of natural products on the treatment of pre-diabetes. Clin J Chin Med. (2021) 13:144–8. doi: 10.3969/j.issn.1674-7860.2021.16.045
13. Ríos, JL, Francini, F, and Schinella, GR. Natural products for the treatment of type 2 diabetes mellitus. Planta Med. (2015) 81:975–94. doi: 10.1055/s-0035-1546131
14. Liu, S, Liu, Q, Sun, S, Li, C, Huan, Y, Chen, Y, et al. Anti-diabetic effects of the fraction of alkaloids from Ramuius Mori, aninnovative Sangzhi alkaloids as an a-glucosidase inhibitor. Acta Pharm Sin. (2019) 54:1225–33. doi: 10.16438/j.0513-4870.2019-0212
15. Wang, Y, Liu, H, Zheng, M, Yang, Y, Ren, H, Kong, Y, et al. Berberine slows the progression of prediabetes to diabetes in Zucker diabetic fatty rats by enhancing intestinal secretion of glucagon-like Peptide-2 and improving the gut microbiota. Front Endocrinol (Lausanne). (2021) 12:609134. doi: 10.3389/fendo.2021.609134
16. Deng, S, Yang, L, Ma, K, and Bian, W. Astragalus polysaccharide improve the proliferation and insulin secretion of mouse pancreatic β cells induced by high glucose and palmitic acid partially through promoting mi R-136-5p and mi R-149-5p expression. Bioengineered. (2021) 12:9872–84. doi: 10.1080/21655979.2021.1996314
17. Clifton, PM, Galbraith, C, and Coles, L. Effect of a low dose whey/guar preload on glycemic control in people with type 2 diabetes--a randomised controlled trial. Nutr J. (2014) 13:103. doi: 10.1186/1475-2891-13-103
18. Yang, X . The study of preventive function of the Ginsenoside on the rat diabetes Melitus. Yanji, China: Yanbian university (2016).
19. Guo, J, Liao, H, Pan, J, Ye, B, Jian, X, Wei, D, et al. Effect of saponion of Litchi on decreasing blood glucose and controlling blood lipid in hyperlipidemia-fatty liver rats fed by ligh-sugar-fat. Chin J Clin Pharmacol Therap. (2004) 9:1403–7. doi: 10.3969/j.issn.1009-2501.2004.12.018
20. Martínez, LAG, Sánchez-Ruiz, LA, Zuñiga, LY, González-Ortiz, M, and Martínez-Abundis, E. Effect of Gymnema sylvestre administration on glycemic control, insulin secretion, and insulin sensitivity in patients with impaired glucose tolerance. J Med Food. (2021) 24:28–32. doi: 10.1089/jmf.2020.0024
21. Gamede, M, Mabuza, L, Ngubane, P, and Khathi, A. Plant-derived oleanolic acid ameliorates markers of subclinical inflammation and innate immunity activation in diet-induced pre-diabetic rats. Ther Adv Endocrinol Metab. (2020) 11:2042018820935771. doi: 10.1177/2042018820935771
22. Zhang, J, Wu, SY, Wang, L, Wang, GL, and Zhu, DZ. Effects of ursolic acid on fat metabolism in high-fat-fed induced insulin resistance rats. Chin Arch Tradit Chin Med. (2010) 28:975–8. doi: 10.13193/j.archtcm.2010.05.81.zhangj.068
23. Matee, KR, Akinnuga, AM, Siboto, A, Ngubane, P, and Khathi, A. Bredemolic acid restores glucose utilization and attenuates oxidative stress in palmitic acid-induced insulin-resistant C2C12 cells. Endocr Regul. (2022) 56:126–33. doi: 10.2478/enr-2022-0014
24. Santos-Lozano, JM, Rada, M, Lapetra, J, Guinda, Á, Jiménez-Rodríguez, MC, Cayuela, JA, et al. Prevention of type 2 diabetes in prediabetic patients by using functional olive oil enriched in oleanolic acid: the PREDIABOLE study, a randomized controlled trial. Diabetes Obes Metab. (2019) 21:2526–34. doi: 10.1111/dom.13838
25. Wei, H . Influence of Jiawei Yueju decoction on blood glucose, blood lipid and obesity index in patients with prediabetse. China Med Pharm. (2018) 8:63-65+94. doi: 10.3969/j.issn.2095-0616.2018.01.020
26. Mayasari, NR, Susetyowati, WM, and Probosuseno,. Antidiabetic effect of rosella-Stevia tea on Prediabetic women in Yogyakarta, Indonesia. J Am Coll Nutr. (2018) 37:373–9. doi: 10.1080/07315724.2017.1400927
27. Cesar, T, Salgaço, MK, Mesa, V, Sartoratto, A, and Sivieri, K. Exploring the association between Citrus nutraceutical Eriocitrin and metformin for improving pre-diabetes in a dynamic microbiome model. Pharmaceuticals (Basel). (2023) 16:650. doi: 10.3390/ph16050650
28. Xian, J, Wu, C, Song, Z, Liang, B, and Yang, Y. Comparative study of guava tea and green tea in treating middle-aged and elderly women with prediabetes. Shanxi Med J. (2019) 48:1690–2. doi: 10.3969/j.issn.0253-9926.2019.14.017
29. Rezvan, N, Moini, A, Janani, L, Mohammad, K, Saedisomeolia, A, Nourbakhsh, M, et al. Effects of quercetin on adiponectin-mediated insulin sensitivity in polycystic ovary syndrome: a randomized placebo-controlled double-blind clinical trial. Horm Metab Res. (2017) 49:115–21. doi: 10.1055/s-0042-118705
30. Chen, D, Ren, S, Ma, F, Liu, Y, Li, W, Yang, R, et al. Effect of elitea essence on glucose tolerance and insulin secretion in hyperglycemia patients. Chin J Clin Pharmacol. (2023) 39:2020–4. doi: 10.13699/j.cnki.1001-6821.2023.14.010
31. Chuengsamarn, S, Rattanamongkolgul, S, Luechapudiporn, R, Phisalaphong, C, and Jirawatnotai, S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. (2012) 35:2121–7. doi: 10.2337/dc12-0116
32. Barre, DE, and Mizier-Barre, KA. Lignans' potential in pre and post-onset type 2 diabetes management. Curr Diabetes Rev. (2019) 16:2–11. doi: 10.2174/1573399814666180914094520
33. Zuñiga, LY, Aceves-de la Mora, M, González-Ortiz, M, Ramos-Núñez, JL, and Martínez-Abundis, E. Effect of Chlorogenic acid administration on glycemic control, insulin secretion, and insulin sensitivity in patients with impaired glucose tolerance. J Med Food. (2018) 21:469–73. doi: 10.1089/jmf.2017.0110
34. Gaddam, A, Galla, C, Thummisetti, S, Marikanty, RK, Palanisamy, UD, and Rao, PV. Role of fenugreek in the prevention of type 2 diabetes mellitus in prediabetes. J Diabetes Metab Disord. (2015) 14:74. doi: 10.1186/s40200-015-0208-4
35. Derosa, G, D'Angelo, A, and Maffioli, P. Ilex paraguariensis, white mulberry and chromium picolinate in patients with pre-diabetes. Phytother Res. (2020) 34:1377–84. doi: 10.1002/ptr.6611
36. Zhang, C, Deng, J, Liu, D, Tuo, X, Xiao, L, Lai, B, et al. Nuciferine ameliorates hepatic steatosis in high-fat diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway. Br J Pharmacol. (2018) 175:4218–28. doi: 10.1111/bph.14482
37. Méndez-Del Villar, M, Puebla-Pérez, AM, Sánchez-Peña, MJ, González-Ortiz, LJ, Martínez-Abundis, E, and González-Ortiz, M. Effect of Artemisia dracunculus administration on glycemic control, insulin sensitivity, and insulin secretion in patients with impaired glucose tolerance. J Med Food. (2016) 19:481–5. doi: 10.1089/jmf.2016.0005
38. Li, C, Gao, Y, Li, M, and Han, B. Effect of a saponin extracted from Anemarrhenaasphodeloides on blood glucose level in mice. Chin Pharmacol Clin. (2005) 21:22–3. doi: 10.3969/j.issn.1001-859X.2005.04.011
39. Nunes, AR, Costa, EC, Alves, G, and Silva, LR. Nanoformulations for the delivery of dietary anthocyanins for the prevention and treatment of diabetes mellitus and its complications. Pharmaceuticals (Basel). (2023) 16:736. doi: 10.3390/ph16050736
40. Bao, T, Wang, Y, Li, YT, Gowd, V, Niu, XH, Yang, HY, et al. Antioxidant and antidiabetic properties of tartary buckwheat rice flavonoids after in vitro digestion. J Zhejiang Univ Sci B. (2016) 17:941–51. doi: 10.1631/jzus.B1600243
41. Cheng, Z, Hu, M, Tao, J, Yang, H, Yan, P, An, G, et al. The protective effects of Chinese yampolysaccharide against obesity-induced insulin resistance. J Funct Foods. (2019) 55:238–47. doi: 10.1016/j.jff.2019.02.023
42. Hameed, A, Galli, M, Adamska-Patruno, E, Krętowski, A, and Ciborowski, M. Select polyphenol-rich berry consumption to defer or deter diabetes and diabetes-related complications. Nutrients. (2020) 12:2538. doi: 10.3390/nu12092538
43. Liu, H, Xing, Y, Wang, Y, Ren, X, Zhang, D, Dai, J, et al. Dendrobium officinale polysaccharide prevents diabetes via the regulation of gut microbiota in Prediabetic mice. Foods. (2023) 12:2310. doi: 10.3390/foods12122310
44. Nishiyama, T, Mae, T, Kishida, H, Tsukagawa, M, Mimaki, Y, Kuroda, M, et al. Curcuminoids and se-squiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-ay mice. J Agric Food Chem. (2005) 53:959–63. doi: 10.1021/jf0483873
Keywords: prediabetes, natural compounds, oxidative stress, insulin resistance, gut microbiota
Citation: Chen J, Jin L, Chen M, Xu K, Huang Q and He B (2023) Application of natural compounds in the treatment and prevention of prediabetes. Front. Nutr. 10:1301129. doi: 10.3389/fnut.2023.1301129
Edited by:
Alina Kurylowicz, Polish Academy of Sciences, PolandReviewed by:
Phikelelani Siphosethu Ngubane, University of KwaZulu-Natal, South AfricaAzalia Avila-Nava, Hospital Regional de Alta Especialidad de la Península de Yucatán, Mexico
Copyright © 2023 Chen, Jin, Chen, Xu, Huang and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qi Huang, aHE4NzEyMDFAMTYzLmNvbQ==; Beihui He, Z3JhZjMwM0BzaW5hLmNvbQ==
†These authors have contributed equally to this work